Skip to content

OKUR

OnKure Therapeutics, Inc.

NASDAQ · Healthcare · Biotechnology · US

$2.95
−0.34%
Ask drillr
0
Insider buys (3m)
2
Insider sells (3m)
-$1.7K
Net value (3m)
-32.4%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Aug 11, 2026Leverone Jason A. · officer: Chief Financial OfficerA-Award130,611$4.14
Aug 11, 2026Hartley Dylan · officer: Chief Scientific OfficerA-Award50,000$4.14
Aug 11, 2026Leverone Jason A. · officer: Chief Financial OfficerA-Award5,322$4.14
Aug 11, 2026Carruthers R Michael · directorA-Award22,350$4.14
Aug 11, 2026Saccomano Nicholas A · director, officer: President and CEOA-Award150,000$4.14
Aug 11, 2026Saccomano Nicholas A · director, officer: President and CEOA-Award2,359$4.14
Aug 11, 2026Saccomano Nicholas A · director, officer: President and CEOA-Award1,485$4.14
Aug 11, 2026Saccomano Nicholas A · director, officer: President and CEOA-Award8,449$4.14
Aug 11, 2026Saccomano Nicholas A · director, officer: President and CEOA-Award16,898$4.14
Aug 11, 2026Saccomano Nicholas A · director, officer: President and CEOA-Award542,232$4.14
Aug 11, 2026Leverone Jason A. · officer: Chief Financial OfficerA-Award50,000$4.14
Aug 11, 2026Leverone Jason A. · officer: Chief Financial OfficerA-Award5,781$4.14
Aug 11, 2026GREY MICHAEL G · directorA-Award22,350$4.14
Aug 11, 2026Jansen Valerie Malyvanh · directorA-Award22,350$4.14
Aug 11, 2026Manke Isaac · directorA-Award15,300$4.14
Aug 11, 2026Manke Isaac · directorA-Award300,000$4.14
Aug 11, 2026Phillips Andrew John · directorA-Award22,350$4.14
Aug 11, 2026Ratcliffe Liam · directorA-Award22,350$4.14
Aug 11, 2026Mathers Edward T · directorA-Award22,350$4.14
Aug 11, 2026Agresta Samuel · officer: Chief Medical OfficerA-Award131,396$4.14
Aug 11, 2026Agresta Samuel · officer: Chief Medical OfficerA-Award18,588$4.14
Aug 11, 2026Agresta Samuel · officer: Chief Medical OfficerA-Award50,000$4.14
Aug 11, 2026Hartley Dylan · officer: Chief Scientific OfficerA-Award137,603$4.14
Jun 24, 2026Saccomano Nicholas A · director, officer: President and CEOSale86$4.40
Jun 24, 2026Leverone Jason A. · officer: Chief Financial OfficerSale303$4.40
Jun 8, 2026Ratcliffe Liam · directorA-Award1,275$4.30
Jun 8, 2026Carruthers R Michael · directorA-Award7,650$4.30
Jun 8, 2026GREY MICHAEL G · directorA-Award7,650$4.30
Jun 8, 2026Jansen Valerie Malyvanh · directorA-Award7,650$4.30
Jun 8, 2026Phillips Andrew John · directorA-Award7,650$4.30
Institutional positioning

13F filings over the trailing two quarters

New 50Increased 33Reduced 23Sold out 8
FilerActionSharesFiled
RA CAPITAL MANAGEMENT, L.P.Unchanged3,998,333Aug 14, 2026
RA CAPITAL MANAGEMENT, L.P.New Position3,998,333May 15, 2026
BVF INC/ILIncreased3,235,778Aug 14, 2026
ACORN CAPITAL ADVISORS, LLCUnchanged2,839,674May 15, 2026
ACORN CAPITAL ADVISORS, LLCUnchanged2,839,674Aug 14, 2026
StepStone Group LPUnchanged2,660,612Aug 13, 2026
STEPSTONE GROUP LPIncreased2,660,612May 15, 2026
ADAR1 CAPITAL MANAGEMENT, LLCIncreased2,434,941May 18, 2026
ADAR1 Capital Management, LLCReduced2,238,684Aug 14, 2026
PROSIGHT MANAGEMENT, LPIncreased2,154,381May 15, 2026
BVF INC/ILNew Position1,978,972May 15, 2026
VIVO CAPITAL, LLCNew Position1,927,710May 20, 2026
Vivo Capital, LLCUnchanged1,927,710Aug 14, 2026
VESTAL POINT CAPITAL, LPIncreased1,839,819May 15, 2026
Vestal Point Capital, LPReduced1,825,699Aug 14, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 11, 2026